UpCard

RSS

Torasemide

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for UpCard. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use UpCard.

For practical information about using UpCard, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 06/08/2015

Authorisation details

Product details
Name
UpCard
Agency product number
EMEA/V/C/003836
Active substance
Torasemide anhydrous
International non-proprietary name (INN) or common name
Torasemide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QC03CA04
Publication details
Marketing-authorisation holder
Vétoquinol SA
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
31/07/2015
Contact address
Magny-Vernois
F-70 200 Lure
France

Product information

31/07/2015 UpCard - EMEA/V/C/003836 -

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • CARDIOVASCULAR SYSTEM
  • high ceiling diuretics
  • plain sulfonamides

Therapeutic indication

For treatment of clinical signs, including oedema and effusion, related to congestive heart failure in dogs.

Assessment history

How useful was this page?

Add your rating